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ABSTRACT Cryptococcus neoformans causes deadly mycosis in immunocompromised
individuals. Macrophages are key cells fighting against microbes. Extracellular vesicles
(EVs) are cell-to-cell communication mediators. The roles of EVs from infected host cells
in the interaction with Cryptococcus remain uninvestigated. Here, EVs from viable C. neo-
formans-infected macrophages reduced fungal burdens but led to shorter survival of
infected mice. In vitro, EVs induced naive macrophages to an inflammatory phenotype.
Transcriptome analysis showed that EVs from viable C. neoformans-infected macro-
phages activated immune-related pathways, including p53 in naive human and murine
macrophages. Conserved analysis demonstrated that basic cell biological processes,
including cell cycle and division, were activated by infection-derived EVs from both mu-
rine and human infected macrophages. Combined proteomics, lipidomics, and metabo-
lomics of EVs from infected macrophages showed regulation of pathways such as
extracellular matrix (ECM) receptors and phosphatidylcholine. This form of intermacro-
phage communication could serve to prepare cells at more distant sites of infection to
resist C. neoformans infection.
IMPORTANCE Cryptococcus neoformans causes cryptococcal meningitis, which is frequent
in patients with HIV/AIDS, especially in less-developed countries. The incidence of cryp-
tococcal meningitis is close to 1 million each year globally. Macrophages are key cells
that protect the body against microbes, including C. neoformans. Extracellular vesicles
are a group of membrane structures that are released from cells such as macrophages
that modulate cell activities via the transfer of materials such as proteins, lipids, and
RNAs. In this study, we found that Cryptococcus neoformans-infected macrophages pro-
duce extracellular vesicles that enhance the inflammatory response in Cryptococcus-
infected mice. These Cryptococcus neoformans-infected macrophage vesicles also showed
higher fungicidal biological effects on inactivated macrophages. Using omics technology,
unique protein and lipid signatures were identified in these extracellular vesicles.
Transcriptome analysis showed that these vesicles activated immune-related pathways like
p53 in naive macrophages. The understanding of this intermacrophage communication
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could provide potential targets for the design of therapeutic agents to fight this deadly
mycosis.
KEYWORDS extracellular vesicles, Cryptococcus neoformans, proteomics, lipidomics,
metabolomics
Cryptococcosis, a disease manifested mainly by pneumonia and meningitis, is causedprimarily by Cryptococcus neoformans (1). The incidence of cryptococcal meningitis is
estimated to be 223,100 cases per year globally (2). Humans are infected primarily through
inhalation of desiccated yeast. In individuals with intact immunity, infection is usually
asymptomatic and contained in the lung. If the infection is not cleared, a state of latency is
established, which can reactivate when immunity is subsequently impaired (3). Moreover,
the case fatality rate is estimated to be as high as 75% among persons living with HIV/
AIDS in less-developed regions (2). Therefore, the progress and outcome in C. neoformans
infection depend on the interplay between C. neoformans and a healthy host immune
response.
Macrophages are the main phagocytic cells during C. neoformans infection. As the
first line of defense, macrophages play a fundamental role in the control of C. neofor-
mans infection (4). On the one hand, macrophages with M1 polarization can effectively
inhibit the spread of C. neoformans (5). Murine bone marrow-derived macrophages
(BMDMs) stimulated with gamma interferon (IFN-g) effectively suppressed the growth
of C. neoformans, and the effect of IFN-g was augmented by lipopolysaccharide (LPS)
(6). On the other hand, C. neoformans can survive and reproduce inside macrophages
via several mechanisms such as inducing macrophage lysosome damage, modulating
phagosomal pH, and causing alterations in the host cell cycle (7, 8). Consequently,
macrophages can be a niche for C. neoformans to survive and spread. However, the
mechanisms by which intracellular C. neoformans modulates macrophage functions
remain poorly understood, especially at distant sites of infection.
Extracellular vesicles (EVs), or exosomes, are membrane-bound vesicles released by
diverse types of cells that differ in size, ranging from 30 to 1,000 nm in diameter,
although most are in the range of 100 to 150 nm (9). EVs are a vital mode for intercellu-
lar communication since vesicles function as vehicles for the transfer of materials such
as proteins, lipids, and RNAs (10). C. neoformans-derived EVs contain components asso-
ciated with virulence, and their packaging into vesicles allows the delivery of a concen-
trated payload of fungal products to recipient cells (11). C. neoformans-derived EVs can
also stimulate macrophage inflammatory responses, including tumor necrosis factor
alpha (TNF-a) and interleukin-10 (IL-10) production, which enhance macrophage fungi-
cidal activity (12). The use of EVs obtained from a C. neoformans acapsular strain pro-
longed the survival of mice upon C. neoformans infection (13).
Apart from pathogen-derived vesicles, infected host cells can also produce EVs that
can mediate the host immune response (14). Although this topic has been investigated
for bacterial and parasitic pathogenic microbes, little work has been done with fungal
pathogens. THP-1-derived EVs from cells infected with Candida albicans activate extrac-
ellular signal-regulated kinase (ERK) and p38 kinases to increase both the secretion of
proinflammatory cytokines and candidacidal activity (15). Given this observation, there
is a high likelihood that macrophage-derived exosomes are important in other fungal
diseases, but little is known about the composition of host-derived EVs and their
effects on recipient cells in the context of fungal pathogenesis.
In the present study, we first tested the biological effects of EVs secreted by acti-
vated BMDMs after exposure to C. neoformans both in vivo and in vitro. The underlying
signaling pathways triggered by EVs in naive macrophages were investigated using
transcriptional analysis. Finally, the components of vesicles were identified by a multi-
omics technique. Our results show that during C. neoformans infection, EVs secreted by
host activated macrophages could serve as a “priming” signal to shift naive macro-
phages to a proinflammatory phenotype and increase macrophage fungicidal activity.
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EVs from C. neoformans-infected BMDMs lower the fungal burden but decrease
mouse survival in murine experimental cryptococcosis. In preliminary experiments,
we observed that EVs from BMDMs infected with live C. neoformans (live-BM-EVs) regu-
lated macrophage polarization to an M1 phenotype in vitro. Thus, we explored their
potential in vivo effects in a murine experimental cryptococcosis model (Fig. 1). Briefly,
C57BL/6 mice were injected intraperitoneally (i.p.) with live-BM-EVs 1 day before intra-
nasal infection with live C. neoformans. We monitored disease progression and fungal
burdens 2 weeks after infection. CFU in both lungs and brains were lower in the group
treated with live-BM-EVs (Fig. 1A and B). Surprisingly, despite the lower fungal burden,
earlier mouse death was observed in the group treated with live-BM-EVs (Fig. 1C). In
histopathological analyses of lungs (Fig. 1D), more extensive pyogranulomatous
inflammation (red circle) with numerous giant cells (red arrow) and phagocytosis was
observed in the lungs of the live-BM-EV-treated group than in the phosphate-buffered
saline (PBS)-treated group. In histopathological analyses of brains, no significant differ-
ences were detected.
EVs from activated BMDMs regulated the naive BMDM shift to the M1 phenotype.
Next, we examined whether activated BMDM-derived EVs had biological effects on
BMDMs in vitro. To investigate whether viable and dead C. neoformans cells could have
similar effects, different types of EV samples were harvested from activated BMDMs
(Fig. 2A). Naive macrophages were treated with three types of EV samples; EV-nontreated
naive BMDMs were used as the control. The incorporation of these EVs by naive BMDMs
happened by as early as 30 min and increased over time (observed by confocal micros-
copy) (see Fig. S1 in the supplemental material). Next, we examined whether these
ingested EVs affected the antifungal effects of BMDMs. Inducible nitrate production in
macrophages is a vital microbicidal mechanism (16). Therefore, after coincubation with
EVs for 24 h, the supernatant nitrate concentration was determined. None of the three
types of EV samples had an effect on the nitrate levels in the supernatant of macrophages
(Table S1). All three types of EV samples enhanced the efficiency of phagocytosis, with
live-BM-EVs causing the strongest increase in the phagocytosis percentage (Fig. 2B). For
the killing function of macrophages, independent of the opsonin used to promote fungal
ingestion, all EV-treated macrophages showed a higher killing capacity than nontreated
macrophages (Fig. 2C to E). To ascertain the effect of EVs on nonlytic exocytosis, all events
in 12 h using time-lapse microscopy were counted. Each of the three types of EV samples
significantly suppressed the nonlytic exocytosis of macrophages (Fig. 2F). To assess the
polarization of macrophages, we chose representative markers of classically (Ccl2) and
alternatively (Arg1) activated macrophages. Both Ccl2 and Arg1 increased in macrophages
after coincubation with EVs, with the increase of Ccl2 being higher than that of Arg1
(Fig. 2G and H). Compared with non-BM-EVs (EVs from activated BMDMs without C. neofor-
mans infection), these in vitro effects on macrophages between C. neoformans-infected
BM-EVs and non-BM-EVs were comparable except for their fungicidal effects, which were
statistically different between live-BM-EVs and non-BM-EVs, independent of opsonin
(Table S2).
Immune-related pathways in naive BMDMs were activated by live-BM-EVs. To
investigate the underlying genes and pathways involved in the naive macrophage
response to sensing EVs, transcriptome analysis of naive macrophages after treatment
with EVs was performed (EV-nontreated BMDMs were used as a control). Using a fold
change of at least 1.5 and a P value of ,0.05 (for P value calculations, see Materials and
Methods) as cutoffs, there were 220 upregulated and 94 downregulated genes in naive
BMDMs incubated with live-BM-EVs in comparison with BM-EV-nontreated BMDMs
(Fig. 3A; transcriptome analyses of naive BMDMs incubated with Hk-BM-EVs [EVs from
heat-killed C. neoformans-infected activated BMDMs] and non-BM-EVs are presented in
Fig. S2). Gene Ontology (GO) (Fig. 3B and C), widely used in functional annotation and
enrichment analyses (17), and Kyoto Encyclopedia of Genes and Genomes (KEGG) (Fig. 3D
and E) analysis revealed high enrichment of immune-related pathway (Fig. 3D and E, red
squares), including GO terms such as “defense response to virus,” “immune system
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FIG 1 Administration of live-BM-EVs (EVs from live C. neoformans-infected activated BMDMs) decreased fungal
burdens in both lungs and brains but led to shorter survival in murine experimental cryptococcosis. (A) CFU of
mouse brains in EV-treated and nontreated groups. (B) CFU of mouse lungs in EV-treated and nontreated
groups. Each point represents CFU from one mouse. (C) Survival analysis of EV-treated and nontreated groups
(Continued on next page)
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process,” and “innate immune response,” and pathways such as “human papillomavirus
infection” and “p53 signaling.”
Basic cell biological processes, including cell cycle and division, were the shared
targets of EVs from both murine and human infected macrophages. To expand the
FIG 2 All three types of activated BMDM-EVs triggered increased antifungal activity of naive BMDMs during C. neoformans (C.n) infection, while live-BM-
EVs (EVs from live C. neoformans-infected activated BMDMs) had the highest potential. (A) Flowchart of harvesting of the three types of EV samples. (B)
Phagocytosis percentages of naive BMDMs after incubation with three types of EV samples. At least 100 macrophages were counted for each group. (C to
E) Fungicidal activity of naive BMDMs after incubation with three types of EV samples with opsonin 18B7 (C), complement (D), or none (E). (F) Nonlytic
exocytosis of naive BMDMs after incubation with three types of EV samples. (G and H) Macrophage polarization, as measured by mRNA levels of Ccl2 (G)
and Arg1 (H), in naive BMDMs after incubation with three types of EV samples. Non-BM-EVs, EVs from activated BMDMs without C. neoformans infection;
No EVs, EV-nontreated macrophages; Hk, heat killed. Data are shown as the means 6 SD from at least three independent experiments, each performed in
triplicate. An unpaired t test was used to calculate P values.
FIG 1 Legend (Continued)
(n= 9). *, P, 0.05. (D) Representative histopathology of lungs in EV-treated and nontreated groups. The red
circle indicates a granuloma in an infected lung, and the red arrow points at cryptococcal giant cells. Data are
shown as the means 6 SD from at least six mice per group. An unpaired t test was used to calculate P values.
A log rank (Mantel-Cox) test was used to compare the survival differences.
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FIG 3 Transcriptional changes in naive BMDMs incubated with live-BM-EVs. EV-nontreated BMDMs were used as a control. (A) Volcano plot of differentially
expressed genes (DEGs) in EV-treated and untreated groups. Red, upregulated; blue, downregulated (n= 3 for each group). (B and C) GO analysis of
upregulated (B) and downregulated (C) DEGs. (D and E) KEGG analysis of upregulated (D) and downregulated (E) DEGs. Red squares indicate immune-
related pathways.
Zhang et al. ®
March/April 2021 Volume 12 Issue 2 e00279-21 mbio.asm.org 6
 on M























scope of our findings to human macrophages, transcriptome analysis was performed
in naive peripheral blood monocyte-derived macrophages (MDMs) treated with EVs
from live C. neoformans-infected activated MDMs (live-M-EVs). Using fold changes of at
least 1.5 and P values of ,0.05 as cutoffs, there were 599 upregulated and 942 down-
regulated genes in naive MDMs incubated with live-M-EVs, compared with EV-non-
treated MDMs (Fig. 4A; transcriptome analyses of naive MDMs incubated with Hk-M-
EVs and non-M-EVs are presented in Fig. S3). In GO (Fig. 4B and C) and KEGG (Fig. 4D
and E) analyses, the most enriched GOs were cytoplasm and protein binding, pathways
in cancer, and metabolic pathways. Immune-related pathways, including “p53 signal-
ing pathway,” “mTOR signaling pathways,” and “human T-cell leukemia virus, type 1
(HTLV-1) infection,” were observed (Fig. 4D and E, red squares). To identify the shared
effects of infected macrophage EVs, we performed a conserved analysis based on the
transcriptome data from both murine and human macrophages treated with either live-
BM-EVs or live-M-EVs. Thirty-two common differentially expressed genes (DEGs) between
human and mouse macrophages were identified as shared targets (Fig. 4F and G). For
GO conserved analysis, one upregulated and six downregulated genes were identified
as shared GO pathways (Fig. 4B and C, red asterisks). For KEGG conserved analysis, 7 up-
regulated and 13 downregulated genes were identified as shared pathways (Fig. 4D and
E, red asterisks). Basic cell biological processes, including cell cycle and division, were the
shared targets of EVs from both murine and human infected macrophages.
Themain size of EVs secreted by BMDMs was 40 to 60nm in diameter. The phys-
ical features and components of three types of EV samples were identified by dynamic
light scattering (DLS), transmission electron microscopy (TEM), and multi-omics analy-
ses. First, the particle size characteristics were determined by DLS, which provides in-
formation on the mean size of vesicles and the width of the size distribution (18), and
TEM. The main distributions of the three types of EV samples were similar, around 40
to 60 nm (Fig. 5). DLS showed a main size of around 40 nm in diameter (Fig. 5B, D, and
F), while TEM demonstrated a main distribution of 60 nm in diameter (Fig. 5C, E, and
G). The size distributions of EVs from naive BMDMs (without LPS or IFN-g treatment)
were also assessed by DLS and TEM (Fig. S4), and a similar distribution of around 40 to
60 nm was observed.
Proteins and lipids, other than metabolites, are potential signaling mediators in
BMDM-derived EVs. Decreased protein and cholesterol concentrations were observed
in Hk-BM-EVs, with comparable protein-to-cholesterol ratios in all groups (Fig. 6A and
B). We identified 1,481 proteins, 226 lipids, and 59 metabolites in three types of EV
samples by a multi-omics approach (19). Proteomic analysis revealed that 46 proteins
were differentially expressed among these EVs and that “extracellular matrix (ECM)
receptors” was the most enriched pathway (Fig. 6C and D). With regard to lipidomics
(Fig. 6E), phosphatidylcholine (PC), phosphatidylethanolamine (PE), and sphingomyelin
(SM) were the most differentially expressed lipids. For the metabolomic analysis, no
significant difference was detected (Table S3).
Given that all three types of EV samples showed similar biological effects in vitro,
we further identified “core EV components” as those widely present in all three types
of EV samples. A total of 1,151 proteins were detected in all types of EV samples, with no
statistical difference, putatively “core EV proteins” of murine macrophages (Table S4).
Among them, Fn1, Hspg2, Emilin2, Hist1h4a, and Actb were the top five most enriched
proteins.
For lipids, each type of EV sample had a set of 210 commonly detected lipids as
“core EV lipids” of murine macrophages (Table S5). Among these lipids, SM(d18:1/16:0)_A,
PC(16:0/18:1), PC(16:0/20:1)/PC(18:0/18:1), SM(d18:2/24:0), and PC(16:0/16:0)_A were the
top five most enriched lipids. We propose that these proteins and lipids are core compo-
nents of macrophage EVs, widely present in all EVs from murine macrophages and poten-
tially in EVs of other murine cells. Their roles in EV formation, excretion, and function
remain to be defined.
Shared proteins and lipids were identified in Cryptococcus-infected BM-EVs.
Finally, we aimed at identifying EV components associated with Cryptococcus infection.
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FIG 4 Transcriptional changes of naive human MDMs (monocyte-derived macrophages) incubated with live-M-EVs (EVs from live C. neoformans-
infected activated human peripheral MDMs). (A) Differentially expressed genes (DEGs) in EV-treated and untreated groups. Red, upregulated;
(Continued on next page)
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Therefore, proteins and lipids in live-BM-EVs and Hk-BM-EVs were analyzed. Compared
with proteins in non-BM-EVs, 9 upregulated and 15 downregulated proteins were iden-
tified in live-BM-EVs (Fig. 7A); 10 upregulated and 12 downregulated proteins were
determined in Hk-BM-EVs (Fig. 7B). Venn analysis identified four upregulated proteins
(encoded by genes Hspa9, Gria1, Arfgef1/2, and Pfkl) and six downregulated proteins
(encoded by genes Metrnl, Rpl23a, Epb4.1/41, Parvb, Snd1, and Cul4b/4a) in both live-
BM-EVs and Hk-BM-EVs (Fig. 7C and D).
With regard to lipids, compared with non-BM-EVs, SM was the most enriched spe-
cies in both live-BM-EVs and Hk-BM-EVs using the positive-ion mode (Fig. 8A and B).
phosphatidylglycerol (PG), phosphatidylinositol (PI), and galactosylceramides (GalCer)
were statistically different in Hk-BM-EVs using the negative mode (Fig. 8C). The upregu-
lated and downregulated lipid profiles in live-BM-EVs and Hk-BM-EVs are shown in
Fig. 8D to F. Venn analysis identified four shared upregulated lipids [PC(18:0/22:4), PC
(18:0/20:5), SM(d18:2/16:0), and SM(d16:1/22:1)/(d18:2/20:0)] and three downregulated
lipids [SM(d18:1/22:0), SM(d18:1/24:1), and SM(d18:1/24:0)] in both live-BM-EVs and Hk-
BM-EVs (Fig. 8G and H).
Annotated to known subcellular locations, the components (proteins and lipids) of
macrophage EVs associated with Cryptococcus are simplified in Fig. 9.
DISCUSSION
Cell-to-cell communication is vital in physiological processes, including immunity
and defense against pathogens. EVs are proposed to be key players in intercellular
communication as EVs contain protein, lipids, and RNAs (20). On the microbial side, EVs
from pathogens carry abundant virulence factors (21). C. neoformans secreted vesicles
were proposed to function as “virulence bags” because they contain numerous compo-
nents associated with virulence, such as glucuronoxylomannan (GXM), laccase, and
urease (11, 22). However, it is unknown whether host-derived vesicles are involved in
the host response to cryptococcosis.
Here, we demonstrate a proinflammatory role of EVs from BMDMs in vivo.
Treatment with EVs led to a lower fungal burden in mice. Surprisingly, overall host sur-
vival was decreased in the group treated with EVs, which we postulate is due to an
overwhelming proinflammatory response in the lungs of EV-treated mice. This hypoth-
esis is supported by the histopathological analysis and in vitro analysis of classical bio-
logical functions of macrophages. All three types of EV samples increased the fungici-
dal activities of naive BMDMs, with live-BM-EVs showing the highest ability. Given that
nonlytic exocytosis requires viable intracellular fungi (23), the reduction in this fungal
cell exit likely reflects the increased fungicidal activity of EV-treated macrophages.
Host damage in cryptococcosis comes from both direct fungally mediated toxicity
as well as immune-derived damage, and the reduced survival could reflect enhanced
host damage from an EV-stimulated immune response (24). A similar phenomenon
was observed with C. neoformans infection in inducible nitric oxide (iNOS)-deficient
mice, which manifested reduced survival despite controlling the infection, as the result
of an overexuberant inflammatory response (25). Evidence from other intracellular
microbes, including Mycobacterium tuberculosis, Salmonella enterica serovar Typhimurium,
and Toxoplasma gondii, has also shown a common pattern of host-derived EVs enhancing
the host inflammatory response (12, 26).
Analysis of the physical properties of EVs revealed that the main size distribution of
these EVs was around 40 to 60 nm, which suggests that these macrophages produced
exosomes (commonly 30 to 100 nm in diameter), the smaller type of EVs, rather than
microvesicles, which are larger membrane structures (27). Based on our data, DLS
FIG 4 Legend (Continued)
blue, downregulated (n= 3 for each group). (B and C) GO analysis of upregulated (B) and downregulated (C) DEGs. (D and E) KEGG analysis of
upregulated (D) and downregulated (E) DEGs. EGFR, epidermal growth factor receptor. (F) Shared DEGs between MDMs and BMDMs identified
by Venn analysis. (G) Fold changes of shared DEGs between MDMs and BMDMs. Red squares indicate immune-related pathways. Red asterisks
indicate shared GO and KEGG pathways.
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tends to underestimate the size of EVs, so TEM is most probably more accurate than
DLS. Therefore, the main distribution of macrophage EVs was likely to be around
60 nm. The similarity of the size distributions in these EVs, irrespective of whether the
FIG 5 Size distributions of BMDM-EVs under different cryptococcal stimulations. The major size distribution of
BMDM-EVs was around 40 to 60 nm in diameter. (A) Representative TEM image of BMDM-EVs. (B and C)
Frequency distributions of live-BM-EVs (EVs from live C. neoformans-infected activated BMDMs) analyzed by DLS
(B) (n= 192) and TEM (C) (n= 59). (D and E) Frequency distributions of Hk-BM-EVs (EVs from heat-killed C.
neoformans-infected activated BMDMs) analyzed by DLS (D) (n= 329) and TEM (E) (n= 61). (F and G) Frequency
distributions of non-BM-EVs (EVs from activated BMDMs without C. neoformans infection) analyzed by DLS (F)
(n= 289) and TEM (G) (n= 74). HV, high voltage.
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FIG 6 Multi-omics analysis of BMDM-EVs under different cryptococcal stimulations. (A) Protein and cholesterol levels of three types of EV
samples. Lower protein and lipid levels are shown in Hk-BM-EVs (EVs from heat-killed C. neoformans-infected activated BMDMs). *, P, 0.05 by
ANOVA. (B) Ratios of protein to cholesterol in three types of EV samples. (C) Differentially expressed proteins in EVs (n= 3 for each type of
EV). (D) Pathway analysis of differentially expressed proteins in EVs. (E) Differentially expressed lipids in EVs (n= 3 for each type of EV). Live-
BM-EVs, EVs from live C. neoformans-infected activated BMDMs; Non-BM-EVs, EVs from activated BMDMs without C. neoformans infection.
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FIG 7 Differential protein composition in EVs from BMDMs after infection with C. neoformans. (A and B) Differential protein
expression in live-BM-EVs (EVs from live Cryptococcus-infected BMDMs) (A) and Hk-BM-EVs (EVs from heat-killed Cryptococcus-
(Continued on next page)
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macrophage ingested live or dead fungal cells, implies that the assembly of EVs was
mainly determined by the originating cells rather than the viability of the interacting
pathogen. Moreover, lower protein and lipid levels were observed in Hk-BM-EVs, which
indicates that heat-killed C. neoformans-infected macrophages produced fewer EVs.
However, this should be interpreted with caution as all the measurements were per-
formed using EVs secreted from activated macrophages, and it is unknown whether
the production of EVs from activated macrophages is dysregulated relative to naive
macrophages.
Our in vitro data suggest that activated macrophages release EVs that induce naive
macrophages to adopt a proinflammatory phenotype, with live-BM-EVs showing stron-
ger effects. The higher proinflammatory feature of live-BM-EVs may be caused by the
inflammatory synergy between exposure to viable Cryptococcus and IFN-g in macro-
phages (6). The multi-omics analysis also identified components that were dysregu-
lated only in live-BM-EVs, including Fstl3, which can increase the proinflammatory
response of macrophages (28). On the other hand, EVs from infected host cells could also
participate in immune response modulation via the transfer of antigens (Ags) to recipient
cells or signaling such as Toll-like receptor-related pathways (29). Consistent with this, live-
BM-EVs induced a higher enrichment of GOs related to immune responses in naive macro-
phages, such as “defense response to virus” and “innate immune response.” Following the
mouse observations, immune-related p53 signaling, widely reported in the macrophage
response against C. neoformans (30), was observed as a shared target of EVs in both naive
human and murine macrophages.
Furthermore, in EVs associated with C. neoformans (live-BM-EVs and Hk-BM-EVs),
higher levels of alarmin proteins, GRIA1, ARFGEF1/2, and HSPA9, were identified as
shared components. These proteins are immunity modulators via pathways such as
STAT5 (31). Notably, GRIA1, a regulator in glutamatergic signaling (32), and HSPA9, a
stress-associated protein (33), were detected only in EVs from infected macrophages, sug-
gesting specific roles in intercellular communication during infection. The presence of alar-
mins, including heat shock proteins (HSPs), in macrophage EVs was also reported previ-
ously by Pieters et al. (34). Different from the proteomics from human macrophage EVs
associated with infection (35), cytokines were not identified in our murine infected
macrophages.
With regard to lipids associated with cryptococcal infection, PC species replaced
with PC(16:0/22:5)/PC(18:1/20:4), PC(16:0/22:6), PC(17:0/22:6), PC(18:0/20:5), and PC
(18:0/22:4) were induced in infected BM-EVs. These long polyunsaturated fatty acids
are precursors of important mediators of inflammation, such as eicosanoids, and pros-
taglandins (36). For the SM species, SM(d18:1/24:0), decreased in the infection BM-EVs,
was reported to activate macrophages directly (37). In light of these observations, we
propose that activated macrophage EVs during cryptococcal infection may function by
modulating immune responses in recipient cells.
It is worth noting that all macrophage-derived vesicles triggered similar protective
roles in vitro. First, all the vesicles were produced by LPS- and IFN-g-activated macro-
phages, which may directly influence EV composition. The direct role of LPS in modu-
lating macrophage antimicrobial vesicles was previously reported by Ding et al. (38).
Additionally, the proinflammatory effects of EVs may also be caused by host compo-
nents. Among the top core EV proteins in all these EVs, the most enriched protein, Fn1,
also known as an alarmin in macrophage EVs, was associated with inflammatory dis-
ease (34, 39), followed by Hspg2, which was reported to regulate an NF-κB-mediated
pathway (40). SM(d18:1/16:0), the most enriched core EV lipid, increased cell ATP pro-
duction through enhanced aerobic glycolysis (41). Given the similar biological effects
of EVs, our results suggest the need for more detailed characterization of EVs, including
FIG 7 Legend (Continued)
infected BMDMs) (B), compared with non-BM-EVs (n= 3) (statistical analysis by ANOVA followed by Dunnett’s multiple-comparison
test). Log2FC, log2 fold change. (C and D) Venn analysis of upregulated (C) and downregulated (D) proteins in live-BM-EVs and Hk-
BM-EVs. *, P, 0.05; **, P, 0.01; ***, P, 0.001.
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FIG 8 Differential lipid composition in EVs from BMDMs under different cryptococcal stimulations. (A to C) Species percentages of
lipids determined by positive and negative ionization modes in live-BM-EVs (EVs from live Cryptococcus-infected BMDMs) (A) and Hk-
BM-EVs (EVs from heat-killed Cryptococcus-infected BMDMs) (B and C) (n= 3). (D to F) Fold changes of dysregulated lipids determined
by positive and negative ionization modes in live-BM-EVs (D) and Hk-BM-EVs (E and F) (statistical analysis by ANOVA followed by
Dunnett’s multiple-comparison test). (G and H) Venn analysis of upregulated (G) and downregulated (H) lipids in live-BM-EVs and Hk-
BM-EVs. *, P, 0.05; **, P, 0.01; ***, P, 0.001.
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future studies to decipher molecular-level effectors carried in EVs and perhaps manipu-
late the EV composition to achieve beneficial effects in the host.
In conclusion, this study demonstrated that EVs from activated macrophages medi-
ated a proinflammatory signal both in vivo and in vitro, suggesting a potential self-reg-
ulatory loop during the host antifungal response. This study provides a new window
for understanding the interplay between the host and pathogen and indicates new tar-
gets for immune-related therapy in the future.
MATERIALS ANDMETHODS
C. neoformans strain. Strain H99 (serotype A) was grown in yeast extract-peptone-dextrose (YPD) at
30°C with moderate shaking (150 rpm) for 48 h to reach the stationary phase. Heat-killed (Hk) C. neofor-
mans cells prepared by immersion in a water bath at 65°C for 30min. C. neoformans cells were centri-
fuged, counted, and resuspended in Dulbecco’s modified Eagle’s medium (DMEM; Gibco).
Macrophage infection. BMDMs were harvested as previously reported (42). In brief, hind leg bones of
6- to 8-week-old C57BL/6J female mice (National Cancer Institute) were used as a source of BMDMs, which
were then matured at 37°C in 10% CO2 for 6 to 8days in DMEM with 20% L-929 cell-conditioned medium,
10% fetal bovine serum (FBS), 2mM L-glutamine, 1% nonessential amino acids, 1% HEPES buffer, and b-mer-
captoethanol. Macrophages were activated with gamma interferon (0.2 ng/ml) and lipopolysaccharide
(0.5mg/ml) for 18 h before C. neoformans infection and then incubated with either live or heat-killed H99
cells (1 yeast cell per host cell) for 1 h or without any C. neoformans. Free C. neoformans cells were removed
by two gentle washes with PBS. These infected BMDMs were then incubated with FBS-depleted medium at
37°C in 10% CO2 for 6h for EV harvest. MDMs and M1 phenotype MDMs were cultured according to routine
protocols (43). In brief, human peripheral monocytes were harvested from buffy coats of healthy donors by
using CD141 magnetic microbeads. Next, these monocytes were cultured in untreated plates in RPMI 1640
containing 10% FBS plus 1% penicillin-streptomycin (pen-strep) with 25ng/ml granulocyte-macrophage col-
ony-stimulating factor (GM-CSF) for 5days. Fresh medium with GM-CSF was changed on day 3. After 5 days
of differentiation, LPS (500ng/ml) and IFN-g (10ng/ml) were added 2 days before infection. The harvesting of
EVs from MDMs was based on the same protocol as the one described above for BMDMs. In this study, acti-
vated macrophages were used to isolate EVs. The usage of human blood samples was approved by
Shanghai Changzheng Hospital under project NSFC 31770161. All animal experiments were approved by the
Johns Hopkins University IACUC under protocol MO18H152.
FIG 9 Simplified model of components in EVs from cryptococcus-infected macrophages. Red shapes indicate upregulated proteins or lipids. Blue shapes
indicate downregulated proteins or lipids. Components in non-BM-EVs were used as controls. Rectangles indicate shared proteins in infection BM-EVs.
Asterisks indicate proteins differentially regulated in live-BM-EVs. Pentagons indicate shared lipids. Circles indicate lipids identified only in live-BM-EVs. Both
membrane-associated and intracellular components were found in EVs from cryptococcus-infected macrophages.
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EV isolation. EVs were isolated according to a previously described method, with some modifica-
tions (11). In brief, the supernatant of the culture suspension from each group was collected, followed
by sequential centrifugations at 450 g for 10min at 4°C followed by 3,000 g for 10min at 4°C. The su-
pernatant passed through an 0.8-mm filter and concentrated using a 100-kDa membrane. The concentrate
was then ultracentrifuged at 100,000 g for 2 h at 4°C. Pellets were washed with sterile PBS, followed by
centrifugation at 12,000 g for 5min, and the supernatant was then ultracentrifuged again at 100,000 g
for 60min. Pellets were resuspended in sterile PBS for subsequent experiments. In this study, we extracted
vesicles from cell culture media under three conditions: macrophages incubated with live Cryptococcus cells,
macrophages incubated with heat-killed Cryptococcus cells, and macrophages only.
EV quantification. A Micro BCA protein assay kit (Thermo Fisher) and an Amplex red cholesterol
assay kit (Thermo Fisher) were used to detect whole protein and cholesterol, respectively. All experi-
ments were performed according to the manuals.
Dynamic light scattering. EV sizes (z-averaged diameter) were measured by dynamic light scatter-
ing (DLS) using Zetasizer (Nano ZS; Malvern). EVs were obtained by ultracentrifugation and diluted in
PBS, samples were then transferred to a disposable cuvette, and 10 measurements for each sample were
performed with a refractive index of 1.33 and absorption at 0.01. Data analysis was performed using
Zetasizer 7.11 software (Malvern).
Coculture of macrophages with EVs. The amount of EVs added to macrophages was based on a
protocol described previously by Oliveira et al. (12). In brief, 1 106 naive macrophages were seeded in
a 6-well plate, and an amount of EVs corresponding to 400 ng cholesterol was added to activate macro-
phages. Cells were incubated at 37°C in 10% CO2 for 24 h. For experiments with C. neoformans challenge,
live C. neoformans cells at a ratio of 1:1 were added to macrophages after a 24-h incubation with EVs,
unless otherwise described.
Nitrite measurement. A Griess assay was used to detect the concentration of nitrite in the superna-
tant, as previously described, with minor modifications (44). In brief, the culture supernatant in 100ml
was collected, and an equal volume of Griess reagent (1:1 ratio of 0.1% naphthyl ethylenediamine dihy-
drochloride and 1% sulfanilamide in 5% H3PO4) was added. The mixture was incubated in the dark for
10min at room temperature. The absorbance of the mixture was measured at 562 nm using the EMax
Plus microplate reader (Molecular Devices). The nitrite concentration was determined from a standard
curve constructed with 0mM to 50mM sodium nitrite.
Real-time PCR. Total RNA was extracted using TRIzol (Ambion). The quantity and quality of RNA
were validated by using a Nanodrop 2000 system (Thermo Fisher). cDNA was synthesized using a high-
capacity cDNA reverse transcription (RT) kit (Applied Biosystems). Real-time PCR was performed using
SYBR green according to the manufacturer’s instructions. The primers were designed and subjected to
NCBI BLAST analysis (https://blast.ncbi.nlm.nih.gov/). The sequences are as follows: forward primer
CAGCAACTCCCACTCTTCCAC (59 to 39) and reverse primer GGTCCAGGGTTTCTTACTC (59 to 39) for glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), forward primer TGACATCAACACTCCCCTGACAAC (59 to 39) and
reverse primer CCTTTTCTTCCTTCCCAGCAG (59 to 39) for Arg1, and forward primer CCTGCTGTTCACAGTTGCC
(59 to 39) and reverse primer ATTGGGATCATCTTGCTGGT (59 to 39) for Ccl2.
Phagocytosis. Phagocytosis was performed according to the protocol described previously by
Nicola and Casadevall, with some minor modifications (45). In brief, 5 104 macrophages were seeded
on 3-ml plates. After incubation with EVs for 24 h, 1.5 105 live C. neoformans cells with 20% comple-
ment (as opsonin) were added and incubated for 2 h. Ice-cold methanol was used to fix the cells, and
cells were washed twice with PBS. Giemsa stain was added to each plate, and the mixture was incubated
at 4°C overnight. An inverted microscope was used to observe phagocytosis. For phagocytosis percen-
tages, the number of macrophages internalizing fungal cells was divided by the total number of macro-
phages. At least 100 macrophages were counted for each group.
Time-lapse microscopy. Approximately 3 104 cells were seeded into a 3-ml plate with a coverslip
at the bottom. After being treated with EVs for 24 h (24 ng EVs), 1.5 105 live C. neoformans cells with
10mg/ml 18B7 antibody (used as opsonin) were added. Cells were incubated at 37°C in 10% CO2 for 2 h
to allow phagocytosis to proceed. After 5 washes with medium to remove extracellular C. neoformans,
2ml medium without 10mg/ml 18B7 was added. Time-lapse images were taken every 4 min for a period
of 12 h at 37°C with 10% CO2 at a 10 magnification on an Axiovert 200M microscope (Zeiss). Time-lapse
movies were analyzed using AxioVision software (Zeiss), and the number of cells exhibiting nonlytic exo-
cytosis was recorded by operator visual analysis of the movie.
Transmission electron microscopy. EVs were adsorbed to glow-discharged (EMS GloQube) carbon-
coated 400-mesh copper grids (EMS) by floatation for 2min. Grids were quickly blotted and then rinsed
in 3 drops (1min each) of Tris-buffered saline (TBS). Grids were negatively stained with 2 consecutive
drops of 1% uranyl acetate, blotted, and then quickly aspirated to obtain a thin layer of stain covering
the sample. Grids were imaged on a Phillips CM-120 transmission electron microscope operating at
80 kV with an AMT XR80 charge-coupled-device (CCD) camera (8 megapixels).
Confocal microscopy. Confocal microscopy was performed as described previously by Gonçalves et
al. (46). In brief, BMDMs were plated at 2 105 cells/well into 24-well plates, covered with a sterile glass
coverslip, and cultured overnight at 37°C in 10% CO2. EVs (20mg protein) were stained with 3mM DiI
(1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate [DiIC18]; Life Technologies) at 4°C
for 30min. EVs were ultracentrifuged at 100,000 g for 1 h and then resuspended in 3ml of 0.22-mm-fil-
tered PBS. EVs were added to BMDMs and incubated for different intervals (30min, 60min, 2 h, 4 h, and
8 h). After the incubations, cells were washed and fixed with 4% paraformaldehyde for 40min at 37°C.
Cells were washed and blocked with 1% PBS–bovine serum albumin (BSA) for 1 h. Cells were washed
and labeled with cholera toxin subunit B (CtxB) (recombinant)-Alexa Fluor 488 (Sigma-Aldrich) at 1mg/
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ml for 1 h at 40°C. After three more washes, cells were labeled with 49,6-diamidino-2-phenylindole
(DAPI) (10mg/ml) for 30min at room temperature. The coverslips were washed three times with PBS and
mounted in a solution containing 50% glycerol and 50mM n-propyl gallate in PBS. The slides were
visualized using a Zeiss LSM 710NLO-Meta confocal microscope with a 40 objective. DAPI-labeled cell
nuclei were excited with a two-photon excitation regime using a Mai Tai HPpulsed infrared laser
(Spectra-Physics, Lasers) at 740 nm. CtxB-Alexa Fluor 488- and DiIC18-labeled EVs were excited with an ar-
gon-ion laser at 488 nm and a diode laser at 561 nm, respectively. Emissions were collected in three sep-
arated channels using band-pass filters for green (BP 500 to 550 IR), red (BP 575 to 615 IR), and blue (BP
435 to 485 IR) channels. All images were collected using AxioVision 4.8. software (Carl Zeiss). Pinhole
diameters were set to 1 Airy unit, corresponding to a z resolution of 0.8mm. The displayed results are
representative of those from three independent experiments.
Killing assay. Approximately 3 104 macrophages were plated in 96-well plates. After incubation
with EVs (24 ng) for 24 h, live C. neoformans cells were added at a ratio of 1:1 with either 10mg/ml 18B7
or 20% guinea pig complement as an opsonin, or C. neoformans cells were added alone. After 2 h of
phagocytosis, the supernatant was removed, followed by five gentle washes with PBS to remove extrac-
ellular C. neoformans. Sterile water was added and pipetted up and down several times to lyse macro-
phage cells. The suspension was then 100-fold diluted, 50ml was added to YPD plates (in triplicates),
and the plates were incubated at 30°C for 2 days before counting individual colonies.
Multi-omics analysis. EVs were placed in a 50-ml conical tube, and liquids were removed. Next, EVs
were dried by placing the tube upside down for several hours and stored at 280°C. Samples were sent
to the Pacific Northwest National Laboratory (PNNL) for multi-omics (proteomic, metabolomic, and lipi-
domic) detection (19). For simultaneous metabolite, protein, and lipid extraction (MPLEx), 5 volumes of
220°C chloroform-methanol (2:1) were added and incubated on ice for 5 min, spun for 1 min, and cen-
trifuged at 12,000 rpm for 10 min at 4°C. The phases containing metabolites and lipids at the top and
bottom, respectively, were collected in an autosampler tube and dried in a vacuum centrifuge. The pro-
tein particles were washed by adding 1ml of 220°C methanol and centrifuged at 12,000 rpm for 10min
at 4°C. The supernatant was discarded, and the precipitated protein was dried in a vacuum centrifuge.
Hydrophilic metabolites were derivatized with methoxamine and N-methyl-N-(trimethylsilyl)trifluoroace-
tamide (MSTFA) and analyzed on a GC 7890A gas chromatography-mass spectrometry (GC-MS) system
(Agilent Technologies) as previously described (47). Data were analyzed with MetaboliteDetector (48),
and metabolites were identified by matching against the PNNL augmented version of the Fiehn Library
(49). Lipids were dissolved in methanol and analyzed by reverse-phase chromatography (Waters CSH
column, 3.0mm by 150mm, 1.7-mm particle size) in a NanoAcquity ultraperformance liquid chromatog-
raphy (UPLC) system (Waters) interfaced with a Velos Orbitrap mass spectrometer (Thermo Fisher) as
described previously (50). Lipid species were identified with LIQUID (50) and manually inspected before
having the features (peak areas) extracted with MZmine 2.0 (51). Proteins were digested with trypsin
(19) and analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a Q-Exactive
mass spectrometer (Thermo Fisher) as described previously by Coelho et al. (21). LC-MS/MS data were
analyzed using MaxQuant (version 1.5.5.1) (52) by searching against the C. neoformans H99 and mouse
reference proteome databases from the UniProt Knowledge Base (both downloaded on 14 August
2018). Only peptides with trypsin cleavage in both termini were considered, with up to 2 missed cleav-
age sites. Cysteine carbamidomethylation was considered an invariable modification, while protein N-
terminal acetylation and methionine oxidation were considered variable modifications. Label-free quan-
tification (LFQ) was used for quantitative analysis. Metabolomics, lipidomics, and proteomics data were
normalized by linear regression and central tendency, followed by analysis of variance (ANOVA) using
Inferno RDN (formerly Dante) (53).
Transcriptome analysis. Genespring (version 14.8; Agilent Technologies) was used to process the
raw data. In brief, the raw data were normalized with the quantile algorithm. For subsequent comparisons,
at least one set of samples must have a positive "detected" signal. Differentially expressed genes were
then identified through fold changes as well as P values calculated with a t test. The cutoff set for up- and
downregulated genes was a fold change of$1.5 and a P value of#0.05. Next, GO analysis and KEGG anal-
ysis were performed to determine the regulatory roles of these differentially expressed mRNAs.
In vivo infection. Animal studies were performed using 6- to 8-week-old female C57BL/6 mice. Each
mouse was injected i.p. with 150mg protein (resuspended in 150ml PBS) 1 day before H99 challenge. H99
cells were grown for 18h at 37°C with shaking at 180 rpm in YPD broth, followed by a wash with PBS, and
resuspended to 2.5 107 cells/ml PBS. Mice were then anesthetized with 2% isoflurane anesthesia, followed
by intranasal infection with a 20-ml H99 suspension. At 2 weeks postinjection, mice were euthanized, and
lung and brain were removed and homogenized by passing through a 100-mm filter. Homogenates were
diluted and plated onto YPD agar for CFU counting. Survival analysis was also performed.
Statistical analysis. Data are reported as the means from at least three independent experiments.
Continuous variables were displayed as the means 6 standard deviations (SD) and compared by
Student’s t test. The survival difference was determined using the log rank test, and P values of ,0.05
were considered statistically significant. All statistical analyses were performed with GraphPad Prism
software (GraphPad, La Jolla, CA, USA). Venn analysis was performed based on InteractiVenn (54).
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